The impact of focused federal initiatives on pediatric cancer research
Subhashini Jagu, Malcolm A. Smith, Nita L. Seibel, Emily S. Tonorezos, Brigitte C. Widemann, Holly A. Gibbons, Mary K. Holohan, Ziky A. Ababiya, Jaime M. Guidry Auvil, Douglas R. Lowy, James H. Doroshow, Anne E. Lubenow, Gregory H. Reaman
TL;DR
Federal programs are improving pediatric cancer research through data sharing and better infrastructure.
Contribution
The paper highlights new federal initiatives aimed at enhancing pediatric cancer research infrastructure and data sharing.
Findings
Federal initiatives are advancing data sharing in pediatric cancer research.
Efforts are strengthening infrastructure for clinical trials and biospecimen collection.
These programs aim to improve treatment outcomes and survivorship in pediatric cancer patients.
Abstract
Federal initiatives, including the Childhood Cancer Data Initiative and the Childhood Cancer Survivorship, Treatment, Access, and Research Act, are advancing pediatric cancer data sharing and strengthening infrastructure required for clinical trials, biobanking, and biospecimen collection. These efforts aim to transform pediatric cancer research to ultimately improve treatment outcomes, quality of life, and survivorship.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsChildhood Cancer Survivors' Quality of Life · Acute Lymphoblastic Leukemia research · Ethics and Legal Issues in Pediatric Healthcare